Serum Biomarkers Identification Using Quantitative Proteomics In Patients With Her2-Positive Inflammatory Breast Cancer Receiving Trastuzumab Plus Bevacizumab-Based Chemotherapy (Beverly 2 Trial)
CANCER RESEARCH（2013）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要